Revolutionize Pharma Manufacturing with Globela's Cutting-Edge Infrastructure
Your Partner in Drug Discovery, Clinical Development and GMP Manufacturing
Production
Our production infrastructure comprises three dedicated blocks with a combined capacity of 370 KL. Featuring 62 reactors ranging from 0.5 KL to
10 KL, we ensure versatility and efficiency in meeting production needs.
R&D
Our R&D division features two DSIR-approved, state-of-the-art facilities.
With a track record of over 110 successfully developed molecules, we’re
committed to innovative pharmaceutical research.